Table of Content
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Lung Cancer Diagnostics Market
6. Market Share – Global Lung Cancer Diagnostics Analysis
6.1 By Diagnosis Test Type
6.2 By Cancer Type
6.3 By EndUsers
6.4 By Country
7. Diagnosis Test Type – Global Lung Cancer Diagnostics Market
7.1 Imaging Test
7.2 Biopsy
7.3 Sputum Cytology
7.4 Molecular Test
7.5 Others
8. Cancer Type – Global Lung Cancer Diagnostics Market
8.1 Non- Small Cell Lung Cancer
8.2 Small Cell Lung Cancer
9. End-User – Global Lung Cancer Diagnostics Market
9.1 Hospital Associated Labs
9.2 Independent Diagnostic Laboratories
9.3 Diagnostic Imaging Centers
9.4 Cancer Research Institutes
9.5 Others
10. Country – Global Lung Cancer Diagnostics Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa
11. Porter’s Five Analysis – Global Lung Cancer Diagnostics Market
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis – Global Lung Cancer Diagnostics Market
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Company Analysis – Global Lung Cancer Diagnostics Market
13.1 llumina
13.1.1 Overviews
13.1.2 Recent Development
13.1.3 Revenues
13.2 Abbott Laboratories
13.2.1 Overviews
13.2.2 Recent Development
13.2.3 Revenues
13.3 Thermo Fisher Scientific, Inc
13.3.1 Overviews
13.3.2 Recent Development
13.3.3 Revenues
13.4 QIAGEN N.V.
13.4.1 Overviews
13.4.2 Recent Development
13.4.3 Revenues
13.5 Roche Holding AG.
13.5.1 Overviews
13.5.2 Recent Development
13.5.3 Revenues
13.6 Sanofi S.A.
13.6.1 Overview
13.6.2 Recent Development
13.6.3 Financial Insights
13.7 Agilent Technologies
13.7.1 Overview
13.7.2 Recent Development
13.7.3 Financial Insights
13.8 bioM?rieux
13.8.1 Overview
13.8.2 Recent Development
13.8.3 Financial Insights
List of Figures
Figure-01: Global – Lung Cancer Diagnostics Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Lung Cancer Diagnostics Market (Billion US$), 2024 – 2030
Figure-03: Diagnosis Test Type – Imaging Test Market (Million US$), 2019 – 2023
Figure-04: Diagnosis Test Type – Forecast for Imaging Test Market (Million US$), 2024 – 2030
Figure-05: Diagnosis Test Type – Biopsy Market (Million US$), 2019 – 2023
Figure-06: Diagnosis Test Type – Forecast for Biopsy Market (Million US$), 2024 – 2030
Figure-07: Diagnosis Test Type – Sputum Cytology Market (Million US$), 2019 – 2023
Figure-08: Diagnosis Test Type – Forecast for Sputum Cytology Market (Million US$), 2024 – 2030
Figure-09: Diagnosis Test Type – Molecular Test Market (Million US$), 2019 – 2023
Figure-10: Diagnosis Test Type – Forecast for Molecular Test Market (Million US$), 2024 – 2030
Figure-11: Diagnosis Test Type – Others Market (Million US$), 2019 – 2023
Figure-12: Diagnosis Test Type – Forecast for Others Market (Million US$), 2024 – 2030
Figure-13: Cancer Type – Non- Small Cell Lung Cancer Market (Million US$), 2019 – 2023
Figure-14: Cancer Type – Forecast for Non- Small Cell Lung Cancer Market (Million US$), 2024 – 2030
Figure-15: Cancer Type – Small Cell Lung Cancer Market (Million US$), 2019 – 2023
Figure-16: Cancer Type – Forecast for Small Cell Lung Cancer Market (Million US$), 2024 – 2030
Figure-17: End-User – Hospital Associated Labs Market (Million US$), 2019 – 2023
Figure-18: End-User – Forecast for Hospital Associated Labs Market (Million US$), 2024 – 2030
Figure-19: End-User – Independent Diagnostic Laboratories Market (Million US$), 2019 – 2023
Figure-20: End-User – Forecast for Independent Diagnostic Laboratories Market (Million US$), 2024 – 2030
Figure-21: End-User – Diagnostic Imaging Centers Market (Million US$), 2019 – 2023
Figure-22: End-User – Forecast for Diagnostic Imaging Centers Market (Million US$), 2024 – 2030
Figure-23: End-User – Cancer Research Institutes Market (Million US$), 2019 – 2023
Figure-24: End-User – Forecast for Cancer Research Institutes Market (Million US$), 2024 – 2030
Figure-25: End-User – Others Market (Million US$), 2019 – 2023
Figure-26: End-User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-27: United States – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-28: United States – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-29: Canada – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-30: Canada – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-31: France – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-32: France – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-33: Germany – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-34: Germany – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-35: Italy – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-36: Italy – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-37: Spain – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-38: Spain – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-39: United Kingdom – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-40: United Kingdom – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-41: Belgium – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-42: Belgium – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-43: Netherlands – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-44: Netherlands – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-45: Turkey – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-46: Turkey – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-47: China – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-48: China – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-49: Japan – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-50: Japan – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-51: India – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-52: India – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-53: South Korea – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-54: South Korea – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-55: Thailand – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-56: Thailand – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-57: Malaysia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-58: Malaysia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-59: Indonesia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-60: Indonesia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-61: Australia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-62: Australia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-63: New Zealand – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-64: New Zealand – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-65: Brazil – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-66: Brazil – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-67: Mexico – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-68: Mexico – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-69: Argentina – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-70: Argentina – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-71: Saudi Arabia – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-72: Saudi Arabia – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-73: UAE – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-74: UAE – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-75: South Africa – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-76: South Africa – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-77: llumina – Lung Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-78: llumina – Forecast for Lung Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-79: Abbott Laboratories – Global Revenue (Million US$), 2019 – 2023
Figure-80: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-81: Thermo Fisher Scientific, Inc – Global Revenue (Million US$), 2019 – 2023
Figure-82: Thermo Fisher Scientific, Inc – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-83: QIAGEN N.V. – Global Revenue (Million US$), 2019 – 2023
Figure-84: QIAGEN N.V. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-85: Roche Holding AG. – Global Revenue (Million US$), 2019 – 2023
Figure-86: Roche Holding AG. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-87: Sanofi S.A. – Global Revenue (Million US$), 2019 – 2023
Figure-88: Sanofi S.A. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-89: Agilent Technologies – Global Revenue (Million US$), 2019 – 2023
Figure-90: Agilent Technologies – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-91: bioM?rieux – Global Revenue (Million US$), 2019 – 2023
Figure-92: bioM?rieux – Forecast for Global Revenue (Million US$), 2024 – 2030
List of Tables
Table-01: Global – Lung Cancer Diagnostics Market Share by Diagnosis Test Type (Percent), 2019 – 2023
Table-02: Global – Forecast for Lung Cancer Diagnostics Market Share by Diagnosis Test Type (Percent), 2024 – 2030
Table-03: Global –Lung Cancer Diagnostics Market Share by Cancer Type (Percent), 2019 – 2023
Table-04: Global – Forecast for Lung Cancer Diagnostics Market Share by Cancer Type (Percent), 2024 – 2030
Table-05: Global – Lung Cancer Diagnostics Market Share by End-User (Percent), 2019 – 2023
Table-06: Global – Forecast for Lung Cancer Diagnostics Market Share by End-User (Percent), 2024 – 2030
Table-07: Global – Lung Cancer Diagnostics Market Share by Region (Percent), 2019 – 2023
Table-08: Global – Forecast for Lung Cancer Diagnostics Market Share by Region (Percent), 2024 – 2030